Skip to main content Accessibility help

Modeling Transmission of Methicillin-Resistant Staphylococcus Aureus Among Patients Admitted to a Hospital

  • Janet Raboud (a1) (a2), Refik Saskin (a2), Andrew Simor (a3) (a4), Mark Loeb (a5), Karen Green (a6), Don E. Low (a6) (a3) and Allison McGeer (a6)...



To determine the impact of the screening test, nursing workload, handwashing rates, and dependence of handwashing on risk level of patient visit on methicillin-resistant Staphylococcus aureus (MRSA) transmission among hospitalized patients.


General medical ward.


Monte Carlo simulation was used to model MRSA transmission (median rate per 1,000 patient-days). Visits by healthcare workers (HCWs) to patients were simulated, and MRSA was assumed to be transmitted among patients via HCWs.


The transmission rate was reduced from 0.89 to 0.56 by the combination of increasing the sensitivity of the screening test from 80% to 99% and being able to report results in 1 day instead of 4 days. Reducing the patient-to-nurse ratio from 4.3 in the day and 6.8 at night to 3.8 and 5.7, respectively, reduced the number of nosocomial infections from 0.89 to 0.85; reducing the ratio to 1 and 1, respectively, further reduced the number of nosocomial infections to 0.32. Increases in handwashing rates by 0%, 10%, and 20% for high-risk visits yielded reductions in nosocomial infections similar to those yielded by increases in handwashing rates for all visits (0.89, 0.36, and 0.24, respectively). Screening all patients for MRSA at admission reduced the transmission rate to 0.81 per 1,000 patient-days from 1.37 if no patients were screened.


Within the ranges of parameters studied, the most effective strategies for reducing the rate of MRSA transmission were increasing the handwashing rates for visits involving contact with skin or bodily fluid and screening patients for MRSA at admission. (Infect Control Hosp Epidemiol 2005;26:607- 615)


Corresponding author

Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, 60 Murray Street (Room 5-244), Toronto, Ontario, Canada, M5G 1X5.,


Hide All
1.Ruben, FL, Norden, CW. Staphylococcal infections. In: Evans, AS, Brachman, PS, eds. Bacterial Infections in Humans: Epidemiology and Control. New York: Plenum; 1991.
2.Voss, A, Doebbeling, BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 1995;5:101106.
3.Westh, H, Jarlov, JO, Kjersem, H, Rosdahl, VT. The disappearance of multi-resistant Staphylococcus aureus in Denmark: changes in strains of the 83A complex between 1969 and 1989. Clin Infect Dis 1992;14:11861194.
4.Panlilio, AL, Culver, DH, Gaynes, RP, et al.Methicillin-resistant Staphylococcus aureus in US hospitals. Infect Control Hosp Epidemiol 1992;13:582586.
5.National Nosocomial Infections Surveillance System report: data summary from January 1992 to April 2000. Am J Infect Control 2000;28:429448.
6.Simor, A, Ofner-Agostini, M, Bryce, E, et al.Methicillin-resistant Staphylococcus aureus in Canada: five years of national surveillance. CMAJ 2001;165:2126.
7.Green, K, Saginur, M, Fleming, CA, Low, DE, McGeer, A. MRSA in Ontario: can transmission be controlled? Presented at the Community and Hospital Infection Control Association Conference; May 29-31, 2000; Toronto, Ontario, Canada.
8.Cookson, BD. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 2000;21:398403.
9.Warshawsky, B, Hussain, Z, Gregson, DB, et al.Hospital and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000;21:724727.
10.Pittet, D, Hugonnet, S, Harbarth, S, et al.The effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:13071312.
11.Goetz, A, Posey, K, Fleming, J, et al.Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study. Infect Control Hosp Epidemiol 1999;20:689691.
12.Morgan, M, Evans-Williams, D, Salmon, R, Hosein, I, Looker, DN, Howard, A, The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997. J Hosp Infect 2000;44:227239.
13.Wakefield, DS, Helms, CM, Massanari, RM, Mori, M, Pfaller, M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185192.
14.Conterno, LO, Wey, SB, Castelo, A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:3237.
15.Romero-Vivas, J, Rubio, M, Fernandez, C, Picazo, JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995;21:14171423.
16.Rubin, RJ, Harrington, CA, Poon, A, Dietrich, K, Green, JA, Moiduddin, A. The economic impact of Staphylococcus aureus infection in New York City. Emerg Infect Dis 1999;5:917.
17.Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408411.
18.Harbarth, S, Rutschmann, O, Sudre, P, Pittet, D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182189.
19.Kim, T, Oh, PI, Simor, AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99104.
20.Bryce, EA, Kerschbaumer, V. The cost of doing business: managing MRSA and VRE. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare Associated Infections; March 5-9, 2000; Atlanta, GA.
21.Reboli, AC, John, JF, Platt, CG, Cantey, JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs medical center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990;11:291296.
22.Jorgensen, JH. Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. Eur J Clin Microbiol 1986;5:693696.
23.Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Baltimore: Williams and Wilkins; 1993.
24.Crossley, K, Loesch, D, Landesman, B, Mead, K, Chern, M, Strate, R. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. J Infect Dis 1979;139:273279.
25.Verhoef, J, Beaujean, D, Blok, H, et al.A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999;18:416466.
26.Wenzel, RP, Reagan, DR, Bertino, JS, Baron, EJ, Arias, K. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control 1998;26:103110.
27.Infectious Diseases and Immunization Committee of the Canadian Paediatric Society. Control of methicillin-resistant Staphylococcus aureus in Canadian pediatric institutions is still a worthwhile goal. Paediatrics and Child Health 1999;4:337341.
28.British Society for Antimicrobial Chemotherapy, Hospital Infection Society, Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infections in hospitals. J Hosp Infect 1998;39:253290.
29.Straelens, MJ, Ronveaux, O, Jans, B, Mertens, R, the Groupement pour la Despistage, l'Etude et la Prevention des Infections Hospitalieres. Methicillin-resistant Staphylococcus aureus: epidemiology and control in Belgian hospitals, 1991-1995. Infect Control Hosp Epidemiol 1996;17:503508.
30.Herwaldt, L. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999;106(suppl):S11S18.
31.Haley, RW, Cushion, NB, Tenover, FC, et al.Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614621.
32.Giroux, E, Pujade, G, Legrand, P, Cizea, F, Brun-Buisson, C.Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus in high risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543550.
33.Harbarth, S, Martin, Y, Rohner, P, Henry, N, Auckenthaler, R, Pittet, D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:3439.
34.Rubinovitch, B, Pittet, D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001;47:918.
35.Arnold, MS, Dempsey, JM, Fishman, M, McAuley, PJ, Tibert, C, Vallande, NC.The best hospital practices for controlling MRSA: on the cutting edge. Infect Control Hosp Epidemiol 2002;23:6576.
36.Mylotte, JM. Control of methicillin-resistant Staphylococcus aureus: the ambivalence persists. Infect Control Hosp Epidemiol 1994;15:7377.
37.Styra, R, Low, DE, Conly, J, et al. Quality of life in patients isolated with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA. Abstract 1692.
38.Teare, EL, Barrett, SP. Is it time to stop searching for MRSA? Stop the ritual of tracing colonized people. Br Med J 1997;314:665666.
39.Cohen, SH, Morita, MM, Bradford, M. A seven year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91(suppl): S33S37.
40.Coella, R, Jimenez, J, Garcia, M, et al.Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 900 patients. Eur J Clin Microbiol Infect Dis 1994;13:7481.
41.Papia, G, Louie, M, Traila, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost-effective? Infect Control Hosp Epidemiol 1999;20:473477.
42.Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson, C.Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:17451751.
43.Farrington, M, Redpath, C, Trundle, C, Coomber, S, Brown, NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus infection at a teaching hospital. Quarterly Journal of Medicine 1998;91:539548.
44.Abudu, L, Blair, I, Fraise, A, Cheng, KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001;126:351356.
45.Eriksen, NH, Espersen, F, Rosdahl, V, Jensen, K. Evaluation of methods of detection of nasal carriage of Staphylococcus aureus. Acta Patologica, Microbiologica et Immunologica Scandinavica 1994;106:407412.
46.Davies, S, Zadik, PM. Comparison of methods for the isolation of methicillin-resistant Staphylococcus aureus. J Clin Pathol 1997;50:257258.
47.Gardam, M, Brunton, J, Willey, B, McGeer, A, Low, D, Conly, D. A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2001;22:152156.
48.Kitagawa, Y, Ueda, M, Ando, N, et al.Rapid diagnosis of methicillin-resistant Staphylococcus aureus bacteremia by nested polymerase chain reaction. Ann Surg 1996;224:665671.
49.Raboud, JM, Saskin, R, Wong, K, et al.Patterns of handwashing behavior and visits by healthcare workers to patients on a general medical ward. Infect Control Hosp Epidemiol 2004;25:198202.
50.Jernigan, JA, Clemence, MA, Stott, GA, et al.Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686696.
51.Jernigan, JA, Titus, MG, Groschel, DHM, Getchell-White, SI, Farr, BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496504.
52.Centers for Disease Control and Prevention. National Nosocomial Infection Surveillance (NNIS) System report: data summary from January 1990 to May 1999. Am J Infect Control 1999;27:520532.
53.Karchmer, TB, Cage, EG, Durbin, LJ, Simonton, BJ, Farr, GM. Cost-effectiveness of active surveillance cultures for controlling methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 2002;51:126132.
54.Lucet, J, Chevret, S, Durand-Zaleski, I, Chastang-Cregnier, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003;163:181188.
55.Larson, EL, Early, E, Cloonan, P, Sugruen, S, Parides, M. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000;26:1422.
56.Austin, DJ, Anderson, RM. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philos Trans R Soc Lond B Biol Sci 1999;354:721738.
57.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multi-drug resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.
58.Eveillard, M, Martin, Y, Hidri, N, Boussougant, Y, Joly-Guillou, ML.Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004;25:114120.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed